Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMEC: NSAIDs + Steroids vs Steroids in Corneal Transplantation
NCT05072262Phase 4Recruiting
- Sponsor
- Oslo University Hospital
- Start
- Nov 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nepafenac in cystoid macular edema (CME), inflammation, sponsored by Oslo University Hospital. Started Nov 2022; status: recruiting.
02
Drugs
nepafenac
03
Conditions
cystoid macular edema (CME)inflammation
Beyond the preview
Go deeper on NCT05072262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05072262.